NTAN1P2

Across TCGA pan-cancer cohorts, NTAN1P2 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated NTAN1P2 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher NTAN1P2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated NTAN1P2 expression acts as an unfavorable survival marker, although some lineages such as BRCA and CHOL show a favorable association.

UVM, BRCA, and CESC are the cancer types where NTAN1P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Median	III,IV	0.317	0.721	<.001	75	view →
BRCA	OS	Median	II,III,IV	0.979	0.935	<.001	62	view →
CESC	DFS	Quartile	III,IV	0.166	0.619	.005	50	view →
LGG	DFS	Median	All	0.663	0.807	<.001	46	view →
ACC	DFS	Quartile	All	0.265	0.757	.001	45	view →
KIRC	DFS	Median	III,IV	0.391	0.546	.005	31	view →
STAD	DFS	Tertile	III,IV	0.276	0.559	.007	19	view →
THCA	OS	Quartile	II,III,IV	0.582	1.000	.001	18	view →
LUSC	DFS	Quartile	III,IV	0.427	0.961	.013	15	view →
CHOL	OS	Tertile	All	1.000	0.308	.012	12	view →
LIHC	OS	Tertile	All	0.648	0.373	.006	10	view →
ESCA	OS	Median	III,IV	0.632	0.327	.011	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

NTAN1P2–UVM (DFS)

Open the UVM breakdown →